I am a breastfeeding mother and i want to know if it is safe to use Mizolastinum [INN-Latin]? Is Mizolastinum [INN-Latin] safe for nursing mother and child? Does Mizolastinum [INN-Latin] extracts into breast milk? Does Mizolastinum [INN-Latin] has any long term or short term side effects on infants? Can Mizolastinum [INN-Latin] influence milk supply or can Mizolastinum [INN-Latin] decrease milk supply in lactating mothers?
- DrLact safety Score for Mizolastinum [INN-Latin] is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of Mizolastinum [INN-Latin] may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that Mizolastinum [INN-Latin] may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of Mizolastinum [INN-Latin] low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using Mizolastinum [INN-Latin] We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
It is a not sedative anti-histaminic drug without an anti-muscarinic activity. Avoid its use on patients affected of cardiac arrhythmia or along with erythromycin and/or ketoconazole o si el lactante está tomando un macrólido.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.